We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.
INFI

Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

3 hedge funds and large institutions have $15 invested in Infinity Pharmaceuticals, Inc. in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

99% less capital invested

Capital invested by funds: $2.9K → $15 (-$2.88K)

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
-$2.9K
2
SPIA
Steward Partners Investment Advisory
New York
-$2
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Highlander Capital Management
New Jersey
$9 – – –
AWM
2
Able Wealth Management
New Jersey
$5 +$5 +2,000 New
LFA
3
Livelsberger Financial Advisory
Ohio
$1 +$1 +200 New
XT
4
XTX Topco
Cayman Islands
– -$2.9K -181,068 Closed
SPIA
5
Steward Partners Investment Advisory
New York
– -$2 -100 Closed

INFI Hedge Fund Activity: Q4 2023 in Review

3 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q4 2023, worth a combined $15 — down 99% from $2.9K a quarter earlier.

Fund positioning in INFI was balanced in Q4 2023: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was XTX Topco, exiting entirely with an estimated $2.9K sold.

  • 3 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $15 of Infinity Pharmaceuticals, Inc. stock for Q4 2023, down 99% quarter-over-quarter.
  • 2 funds opened new Infinity Pharmaceuticals, Inc. positions in Q4 2023 and 2 closed out, a net change of 0 holders.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q4 2023 was XTX Topco, an estimated $2.9K sold.

Based on aggregated 13F filings for Q4 2023.